Novartis AG
Parenteral Formulation Comprising Siponimod
Last updated:
Abstract:
The present invention relates to a pharmaceutical formulation of siponimod which can be administered parenterally. In particular, the present invention relates to a parenteral solution comprising siponimod and a method for preparing said solution.
Status:
Application
Type:
Utility
Filling date:
26 Sep 2018
Issue date:
23 Jul 2020